Early Disease Detection Using Next Generation Metabolomics

We help medical practitioners find health problems before they occur.

We analyze metabolic activities in the body which is done by looking at metabolites, small molecules produced or used by a person’s metabolism. With this analysis, we can often find the root cause of current health problems or warn of potential future health issues.

Medical practitioners can then recommend further tests and/or changes in diet, supplementation, or lifestyle to modify the trajectory of a person’s health.

We can also report on how much someone's body has aged biologically compared to their chronological age.

Metabolomycs, Inc. is a Southern California-based biotechnology company that has pioneered the clinical application of next-generation metabolomics for the study of human disease.

Targeted Mass Spectrometry (MS/MS) Testing

Our advanced MS/MS testing platform is designed to identify and quantify metabolic biomarkers associated with Inborn Errors of Metabolism (IEMs). This precise approach allows for early detection of subtle metabolic disturbances, offering insights that are often missed by conventional diagnostics.

Comprehensive IEM Screening

Metabolomycs offers a thorough screening program for over 1,000 known Inborn Errors of Metabolism. Our service enables healthcare providers to detect sub-clinical metabolic disorders, supporting proactive intervention and personalized treatment strategies for patients at risk.

Personalized Disease Management

Leveraging detailed metabolomic data, we empower clinicians with our test reports to tailor treatment plans based on each patient’s unique metabolic profile. This personalized approach enhances disease management and enables more effective monitoring of therapeutic outcomes. Medical practitioners can then recommend further tests and/or changes in diet, supplementation, or lifestyle to modify the trajectory of a person’s health.